113 related articles for article (PubMed ID: 7083909)
21. Clofazimine for leprosy and Mycobacterium avium complex infections.
Med Lett Drugs Ther; 1987 Aug; 29(746):77-8. PubMed ID: 3614089
[No Abstract] [Full Text] [Related]
22. Experiences with clofazimine therapy in leprosy.
Kundu SK; Hazra SK; Choudhury S; Ghosh S
Lepr India; 1976 Oct; 48(4 Suppl):695-702. PubMed ID: 1026806
[No Abstract] [Full Text] [Related]
23. Clofazimine-induced lymphoedema.
Oommen T
Lepr Rev; 1990 Sep; 61(3):289. PubMed ID: 2215062
[No Abstract] [Full Text] [Related]
24. Exfoliative dermatitis after clofazimine.
Pavithran K
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):645-6. PubMed ID: 2935586
[No Abstract] [Full Text] [Related]
25. Clofazimine in lepra (ENL) reaction, one year clinical trial.
Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
[TBL] [Abstract][Full Text] [Related]
26. Complications of treatment with clofazimine (Lamprene: B663).
Jopling WH
Lepr Rev; 1976 Mar; 47(1):1-3. PubMed ID: 1263731
[No Abstract] [Full Text] [Related]
27. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
28. Lamprene (clofazimine) in leprosy. Basic information.
Yawalkar SJ; Vischer W
Lepr Rev; 1979 Jun; 50(2):135-44. PubMed ID: 396428
[No Abstract] [Full Text] [Related]
29. Borderline reactions treated with clofazimine and corticosteroids.
Thirugnanam T; Rajan MA
Indian J Lepr; 1985; 57(1):164-71. PubMed ID: 3839816
[TBL] [Abstract][Full Text] [Related]
30. Reduced estrogen excretion due to clofazimine?
Duncan ME; Oakey RE
Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):112-3. PubMed ID: 6683254
[No Abstract] [Full Text] [Related]
31. Personal experience with clofazimine in the treatment of leprosy.
Azulay RD; da Silva NC; Zeo A; de Jesus M; Franca CB
Lepr Rev; 1975 Jun; 46(2 Suppl):99-103. PubMed ID: 1100972
[No Abstract] [Full Text] [Related]
32. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
Dutta RK
Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
[No Abstract] [Full Text] [Related]
33. Letter: Ocular side-effects of clofazimine.
Ohman L; Wahlberg I
Lancet; 1975 Nov; 2(7941):933-4. PubMed ID: 53420
[No Abstract] [Full Text] [Related]
34. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
[TBL] [Abstract][Full Text] [Related]
35. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
36. Clofazimine in pregnancy.
Holdiness MR
Early Hum Dev; 1989 Feb; 18(4):297-8. PubMed ID: 2702953
[No Abstract] [Full Text] [Related]
37. Clofazimine and the eye: preliminary communication.
Nêgrel AD; Chovet M; Baquillon G; Lagadec R
Lepr Rev; 1984 Dec; 55(4):349-52. PubMed ID: 6527599
[No Abstract] [Full Text] [Related]
38. A review of side-effects experienced by patients taking clofazimine.
Moore VJ
Lepr Rev; 1983 Dec; 54(4):327-35. PubMed ID: 6668986
[No Abstract] [Full Text] [Related]
39. Severe abdominal pain in low dosage clofazimine.
Chong PY; Ti TK
Pathology; 1993 Jan; 25(1):24-6. PubMed ID: 8316494
[TBL] [Abstract][Full Text] [Related]
40. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
Jamet P; Robin Y
Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
